• The number of people living with MCI across the countries under study will increase by 23%, from 22 million in 2016 to 27 million in 2026.
  • Among the countries considered in this analysis, the total prevalence of MCI is highest in Japan, at 217 per 1,000 aged 65 or over in 2016.

Table of contents

  • Mild Cognitive Impairment - Epidemiology - Mature Markets Data

Author(s): Nishant Kumar, MPH

Nishant is a senior epidemiologist and head of oncology within the epidemiology team at Decision Resources Group. He also covers some CNS diseases, including Alzheimer’s disease and dementia. His key interests are developing interactive patient flows, and modelling disease progression to forecast commercially relevant drug-treatable incident and prevalent populations. Nishant also spends a lot of time collaborating with clients to help answer more specific questions through custom work and consulting projects.

His qualifications include an MSc in Public Health with specialization in epidemiology and statistics from King’s College London, and a BSc in Medical Studies from the University of Birmingham.